The adoption of medical device packaging in Southeast Asia is expected to grow at a CAGR of 5.6%. The medical device packaging space is projected to increase from US$ 2,022 million in 2023 to US$ 3,477 million by 2033. Southeast Asia's medical device packaging sales were valued at US$ 1,911 million in 2022, and are anticipated to exhibit Y-o-Y growth of 5.6% in 2023.
Bags and pouches in packaging format are set to grow by 4.7% CAGR from 2023 to 2033, with an estimated value of US$ 355.9 million as of 2023. The surgical devices by application segment held about 12% in 2023 within Southeast Asia. The plastic part, with an estimated share of 62.4%, has a significant valuation within the material type category and is projected to expand at a CAGR of 5.0% through 2033.
Southeast Asia medical device packaging demand is expected to experience a lucrative growth outlook during the forecast period. A new estimation predicts that sales will rise during 2023 to 2033 and is projected to generate an attractive financial opportunity of US$ 1,567 million. It is predicted to expand 1.8x times the current value through 2033.
Medical supplies, surgical instruments and implants, medical electrical equipment, in vitro diagnostic reagents and equipment, irradiation equipment, and other dental tools are vital products that require medical-grade packaging. Unhealthy lifestyles have led to high rates of chronic diseases such as cancer, heart disease, diabetes, stroke, and arthritis in recent years, particularly in industrialized economies. The disorders mentioned above need several medical devices for diagnosis and treatment and contribute to developing the medical devices packaging landscape.
Manufacturers offer products with various technologies, such as peel/seal technology and tampering technology. Manufacturers aim is to provide convenient products and center shot protection. Solutions such as uniquely numbered/serialized 2D barcodes, UV ID codes, holograms, or hidden text printed with security or magnetic inks can provide complete protection.
| Attributes | Key Insights |
|---|---|
| Southeast Asia Medical Device Packaging Sales (2022A) | US$ 1,911 million |
| Southeast Asia Medical Device Packaging Sales (2023E) | US$ 2,022 million |
| Projected Southeast Asia Medical Device Packaging Revenue (2033F) | US$ 3,477 million |
| Value-based CAGR (2023 to 2033) | 5.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The medical device packaging ecosystem in Southeast Asia witnessed a CAGR of 4.6% during the historical period, reaching a value of US$ 1,911 million in 2022 from US$ 1,594.2 million in 2018. The demand for critical services has steadily grown with coordinated investment in infrastructure, medical services, and professional medical training. This makes for a significant opportunity for life science companies to support aging populations in both developed and emerging economies.
The scale and complexity of these challenges suggest that opportunities for enhancement in healthcare systems from both the public and private sectors will likely emerge. To combat the issue of common but treatable health issues, governments play a critical role in increasing the knowledge of and accessibility to health treatments and tools.
In 2018, the Delhi Declaration on Improving Access to Essential Medical Products and the Region's Flagship priority program agreed on achieving universal health coverage. The WHO Southeast Asia chapter is committed to ensuring universal access to safe, effective, affordable, and high-quality medical products for all.
Efforts to minimize risks and dependency and enhance domestic output are ongoing to construct resilient supply chains. Southeast Asia region member countries were actively involved in global consultations that resulted in the passage of crucial World Health Assembly resolutions concerning this topic.
Southeast Asian countries, particularly Thailand and Singapore, have become prime destinations for medical tourism owing to affordable treatments and the availability of complete healthcare under one roof. More patients from developed and emerging economies have traveled to these countries for medical treatments, combining a holiday with an executive check-up or surgery.
Hospitals in these countries have advanced significantly in several medical specialties, including robotic endoscopic coronary bypass surgery, minimally invasive surgery, and heart surgery. This is because of improvements in regional invasive and non-invasive medical technologies, which are predicted to rise in this space.
The development of medical devices in the region is still in its infancy despite the frequent steps governments in Southeast Asia economies have taken to foster local innovation. For instance, the government of Thailand is attempting to boost research and development activity in the medical device sector as part of the new Thailand 4.0 development model by establishing an Intellectual Property Innovation-Driven Entrepreneurship Center (IPI-DE).
The center keeps a database of data and patent details available to small and medium-sized businesses (SMEs) working on any new technology. As a result, the Thai government aims to encourage Thai medical device firms to innovate and expand across domestic and foreign economies.
Principal Consultant
| Attributes | Key Factors |
|---|---|
| Latest Trends |
|
| Growth Hindrances |
|
| Upcoming Opportunities |
|
The table below explains the sales of medical device packaging in Southeast Asia by value and CAGRs of the top 5 countries for 2033. Among them, Malaysia is anticipated to remain at the forefront by registering US$ 746 million. Thailand is expected to secure US$ 429.2 million by 2033, less than Indonesia's US$ 507.9 million.
| Countries | Market Value (2033) |
|---|---|
| Indonesia | US$ 507.9 million |
| Malaysia | US$ 746 million |
| Philippines | US$ 413.5 million |
| Singapore | US$ 318 million |
| Thailand | US$ 429.2 million |
| Vietnam | US$ 424.9 million |
The table below shows the CAGRs of the top 5 countries for the review period 2023 to 2033. Vietnam and Thailand are expected to remain dominant by exhibiting a CAGR of 8.0% and 6.6%, respectively. Singapore and the Philippines are likely to follow with CAGRs of 6.3% and 5.6%, respectively.
| Countries | Value CAGR |
|---|---|
| Indonesia | 3.7% |
| Malaysia | 4.5% |
| Philippines | 5.6% |
| Singapore | 6.3% |
| Thailand | 6.6% |
| Vietnam | 8.0% |
Medical device packaging industry in Singapore is estimated to grow at a CAGR of 6.3% during the forecast period. Singapore is expected to lead the Southeast Asia medical device packaging sales over the forecast period, generating revenue of US$ 318 million by 2033.
According to the Economic Development Board of Singapore, Singapore's aging population and increasing demand for quality healthcare services, vital research and development capabilities, and innovation ecosystem fuel demand in Singapore. As the demand for critical services increases with coordinated investment in infrastructure, medical services, and professional medical training, life science companies have a significant opportunity. There is also a considerable scope to support the emerging industries.
The scale and complexity of these challenges suggest that there may be opportunities for enhancement in healthcare systems from both the public and private sectors. To combat the issue of common but treatable health issues, governments play a critical role in increasing the knowledge of and accessibility to health treatments and tools.
Medical device packaging industry in Indonesia is estimated to grow at a CAGR of 3.7% during the forecast period. Indonesia medical device packaging sales are projected to create a financial potential worth US$ 166.8 million by 2033.
According to the International Trade Association, increased public awareness of the importance of healthcare, the expansion of public and private hospitals, and the establishment of Indonesia's public health insurance system in 2014 have all resulted in a greater demand for more complex and advanced medical technology. Healthcare is a national priority in Indonesia, and the central and provincial governments continue to create and modernize healthcare facilities.
Indonesia now has 2,925 hospitals, with around 63% privately run. Increasing per capita spending on healthcare services, followed by rising healthcare infrastructure in Indonesia and increasing medical tourism, will likely positively impact medical device packaging.
Malaysia is expected to surge at a CAGR of 4.5% by 2033. The country is distinguished by several reputable equipment manufacturing companies functioning locally and globally. Malaysia is a leading exporter of medical equipment worldwide and is in the lead of medical technology innovation and development. Due to these aspects, the demand for medical packaging in the country is projected to increase.
Malaysia holds the leading share due to its strength in the healthcare industry and many units operating in the healthcare sector. It has a competitive benefit in equipment, software development, technology, and high investment in research and development, leading to increased medical device production volumes. Due to Malaysia’s economic growth, a lot of investments are pouring into the healthcare sector.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below signifies leading sub-categories under packaging format and application type categories in the medical device packaging in Southeast Asia segment. Bags and pouches are expected to dominate by exhibiting a 4.7% CAGR in the evaluation period. Under the application type segment, the disposable medical supplies category is projected to lead at a 5.8% CAGR.
| Category | Forecast CAGR (2023 to 2033) |
|---|---|
| Bags and Pouches (Packaging Format) | 4.7% |
| Disposable Medical Supplies (Application Type) | 5.8% |
In terms of packaging, the bags and pouches segment is predicted to lead medical device packaging industry in Southeast Asia in the forecast period, offering a definite financial opportunity of US$ 224.4 million by 2033. Bags and pouches in medical device packaging provide a barrier against contamination, ensuring that the medical device remains sterile until it is ready to be used.
Medical sector players prefer these bags and pouches since they are made of a sterile, durable, and flexible material, which is highly important in this sector. They are renowned to be able to withstand rigorous sterilization processes and package small, medium, and large medical devices efficiently. The high product-to-package and small size ratio allow for easy handling and storage of medical devices, another factor driving their high sales. Manufacturers in this domain are focusing on creating bags and pouches from suitable materials, such as PET and LLDPE, to better enable protection from light, moisture, and gases.
The disposable medical supplies segment under application is estimated to generate high demand for medical device packaging solutions in Southeast Asia. The same segment is anticipated to create a potential financial opening worth US$ 1,167 million by 2033.
The increasing need for disposable medical products is significantly driving sales expansion. Instead of reusable devices, end customers choose disposable medical equipment such as disposable anesthesia face masks. Disposable medical supplies help to keep diseases away. Medical disposable materials are less likely to spread infections than reusable medical equipment. When compared to reusable equipment, disposable gadgets are more cost-effective and efficient.
Due to the growing emphasis on maintaining hygiene and protecting the health of hospital staff and patients, the use of reusable medical equipment, such as masks and gloves, in medical centers has expanded. The increased focus of hospitals on accomplishing legal requirements is driving the demand for reusable medical equipment such as disposable needles, syringes, masks, drapes, and gowns. As a result, the industry for disposable medical supplies is rising.
Manufacturers in the medical device packaging domain prioritize expanding their production capabilities in response to the rising demand in Southeast Asia. Furthermore, these key players are diversifying their product offerings to address the expanding segment for medical device packaging in Southeast Asia.
Key companies acquire other corporations to expand their product portfolio and surge their production capacity. The occurrence of globally renowned public companies is likely to lead to an increase in mergers and acquisitions cases as private and smaller companies cannot compete with companies in international markets regarding revenue generation.
For instance,
| Attribute | Details |
|---|---|
| Estimated Southeast Asia Medical Device Packaging Size (2023) | US$ 2,022 million |
| Projected Southeast Asia Medical Device Packaging Valuation (2033) | US$ 3,477 million |
| Value-based CAGR (2023 to 2033) | 5.6% |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ Million, Volume in Tonnes, and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Material, Packaging Format, Class, Application, Region |
| Key Countries Covered | Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Myanmar, Cambodia, Brunei, Timor-Leste, Laos |
| Key Companies Profiled | Huhtamaki Oyj; WestRock Company; Berry Global, Inc.; Tekni-Plex, Inc.; DuPont Inc; Graphic Packaging International, Inc.; Amcor Plc; Sonoco Products Company; Amcor plc; Berry Southeast Asia, Inc.; Huhtamaki Oyj; PAXXUS PTE LTD; Graphic Packaging International, Inc.; DuPont Inc; Steripack Group; ZACROS Group; Tekni-Plex, Inc.; Stora Enso Oyj; WestRock Company; Constantia Flexibles Group GmbH |
Sales of medical device packaging are expected to surge at a CAGR of 5.6% by 2033.
The worth of the ecosystem in 2022 was US$ 1,911 million.
In 2033, the industry is anticipated to reach US$ 3,477 million.
The increasing need for protective packaging against physical damage solutions.
Top 3 players operating in the ecosystem are Huhtamaki Oyj, WestRock Company, and Berry Global, Inc.
Singapore and Malaysia are the leading countries in the industry.
1. Executive Summary 1.1. Sales Outlook 1.2. Sales Analysis 1.3. FMI Analysis and Recommendations 2. Sales Overview 2.1. Sales Coverage / Taxonomy 2.2. Sales Definition / Scope / Limitations 3. Key Sales Trends 3.1. Key Trends Impacting the Sales 3.2. Sustainable Trends 3.3. Start-up Trends 3.4. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption / Usage Analysis 4.2. Product USPs / Features 4.3. Strategic Promotional Strategies 4.4. Go-to-market Strategies 5. Sales Analysis 2018 to 2022 and forecast, 2023 to 2033 5.1. Historical Sales Volume (Tonnes) Analysis, 2018 to 2022 5.2. Current and Future Sales Volume (Tonnes) Projections, 2023 to 2033 5.3. Y-o-Y Growth Trend Analysis 6. Sales - Pricing Analysis 6.1. Regional Pricing Analysis, By Material (US$/Tonne) 6.2. Average Pricing Analysis Benchmark 7. Sales (in Value or Size in US$ million) Analysis 2018 to 2022 and forecast, 2023 to 2033 7.1. Historical Sales Value (US$ million) Analysis, 2018 to 2022 7.2. Current and Future Sales Value (US$ million) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Sales Background 8.1. Southeast Asia Retail Sales Outlook 8.2. Macro-Economic Factors 8.3. Forecast Factors - Relevance & Impact 8.4. Who Supplies Whom 8.5. Value Chain Analysis 8.5.1. Key Sales Participants 8.5.1.1. Exhaustive List of Component / technology Suppliers 8.5.1.2. Exhaustive List of Machines Format Manufacturers/Integrators 8.5.1.3. Exhaustive List of Application Rs / F&B Brands (Potential Customers) 8.5.2. Profitability Margin 8.6. Case-based Scenario - Impact Assessment 8.6.1. Current Statistics 8.6.2. Short-Mid-Long-Term Outlook 8.6.3. Likely Rebound 8.7. Sales Dynamics 8.7.1. Drivers 8.7.2. Restraints 8.7.3. Opportunity Analysis 8.8. Supply Demand Analysis 8.8.1. Export 8.8.2. Import 8.8.3. Production 9. Sales Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material 9.1. Introduction / Key Findings 9.2. Historical Sales Value (US$ million) & Volume (Tonnes) Analysis by Material, 2018 to 2022 9.3. Current and Future Sales Value (US$ million) & Volume (Tonnes) Analysis and Forecast by Material, 2023 to 2033 9.3.1. Plastic 9.3.1.1. PE 9.3.1.2. PP 9.3.1.3. PET 9.3.1.4. PVC 9.3.1.5. Bioplastics 9.3.1.6. Other Plastics 9.3.2. Aluminum 9.3.3. Glass 9.3.4. Tyvek 9.3.5. Paper & Paperboard 9.3.5.1. Coated 9.3.5.2. Uncoated 9.3.6. Others (Fabric, Silicon, Etc.) 9.4. Y-o-Y Growth Trend Analysis by Material, 2018 to 2022 9.5. Absolute $ Opportunity Analysis by Material, 2023 to 2033 10. Sales Analysis 2018 to 2022 and Forecast 2023 to 2033, By Packaging Format 10.1. Introduction / Key Findings 10.2. Historical Sales Value (US$ million) & Volume (Tonnes) Analysis by Packaging Format, 2018 to 2022 10.3. Current and Future Sales Value (US$ million) & Volume (Tonnes) Analysis and Forecast by Packaging Format, 2023 to 2033 10.3.1. Bags & Pouches 10.3.2. Films & Wraps 10.3.3. Lids 10.3.4. Roll stock 10.3.4.1. Top and bottom 10.3.4.2. Forming webs 10.3.5. Containers 10.3.6. Trays 10.3.7. Medical Device Packs 10.3.8. Clamshell 10.3.9. Blister Packs 10.3.10. Boxes 10.4. Y-o-Y Growth Trend Analysis by Packaging Format, 2018 to 2022 10.5. Absolute $ Opportunity Analysis by Packaging Format, 2023 to 2033 11. Sales Analysis 2018 to 2022 and Forecast 2023 to 2033, By Class 11.1. Introduction / Key Findings 11.2. Historical Sales Value (US$ million) & Volume (Tonnes) Analysis by Class, 2018 to 2022 11.3. Current and Future Sales Value (US$ million) & Volume (Tonnes) Analysis and Forecast Class, 2023 to 2033 11.3.1. Medial Class 2 11.3.2. Medical Class 3 11.4. Y–o–Y Growth Trend Analysis by Class, 2018 to 2022 11.5. Absolute $ Opportunity Analysis by Class, 2023 to 2033 12. Sales Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 12.1. Introduction / Key Findings 12.2. Historical Sales Value (US$ million) & Volume (Tonnes) Analysis by Application, 2018 to 2022 12.3. Current and Future Sales Value (US$ million) & Volume (Tonnes) Analysis and Forecast by Application, 2023 to 2033 12.3.1. Surgical Device 12.3.2. Therapeutic Equipment 12.3.3. Monitoring & Diagnostic Equipment 12.3.4. Disposal Medical Supplies 12.3.4.1. IV Catheters 12.3.4.2. IV Sets 12.3.4.3. Syringes 12.3.4.4. Scalp Vein Sets 12.3.4.5. Drapes 12.3.4.6. Gowns 12.3.4.7. Gloves 12.3.4.8. Wound Care 12.3.4.9. Filter Tubes 12.4. Y–o–Y Growth Trend Analysis by Application, 2018 to 2022 12.5. Absolute $ Opportunity Analysis by Application, 2023 to 2033 13. Sales Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Introduction / Key Findings 13.2. Historical Sales Value (US$ million) & Volume (Tones) Analysis by Country, 2018 to 2022 13.3. Current and Future Sales Value (US$ million) & Volume (Tonnes) Analysis and Forecast by Country, 2023 to 2033 13.3.1. Indonesia 13.3.2. Malaysia 13.3.3. Philippines 13.3.4. Singapore 13.3.5. Thailand 13.3.6. Vietnam 13.3.7. Burma (Myanmar) 13.3.8. Cambodia 13.3.9. Brunei 13.3.10. Timor-Leste 13.3.11. Laos 13.3.12. Rest of Southeast Asia Countries 13.4. Y-o-Y Growth Trend Analysis by Country, 2018 to 2022 13.5. Absolute $ Opportunity Analysis by Country, 2023 to 2033 14. Country wise Machines Sales Cross-Sectional Analysis 2023 to 2033 14.1. Indonesia Machines Sales Analysis 14.1.1. By Material 14.1.2. By Packaging Format 14.1.3. By Class 14.1.4. By Application 14.2. Malaysia Machines Sales Analysis 14.2.1. By Material 14.2.2. By Packaging Format 14.2.3. By Class 14.2.4. By Application 14.3. Philippines Machines Sales Analysis 14.3.1. By Material 14.3.2. By Packaging Format 14.3.3. By Class 14.3.4. By Application 14.4. Singapore Machines Sales Analysis 14.4.1. By Material 14.4.2. By Packaging Format 14.4.3. By Class 14.4.4. By Application 14.5. Thailand Machines Sales Analysis 14.5.1. By Material 14.5.2. By Packaging Format 14.5.3. By Class 14.5.4. By Application 14.6. Vietnam Packaging Machines Sales Analysis 14.6.1. By Material 14.6.2. By Packaging Format 14.6.3. By Class 14.6.4. By Application 14.7. Burma (Myanmar) Packaging Machines Sales Analysis 14.7.1. By Material 14.7.2. By Packaging Format 14.7.3. By Class 14.7.4. By Application 14.8. Cambodia Packaging Machines Sales Analysis 14.8.1. By Material 14.8.2. By Packaging Format 14.8.3. By Class 14.8.4. By Application 14.9. Brunei Packaging Machines Sales Analysis 14.9.1. By Material 14.9.2. By Packaging Format 14.9.3. By Class 14.9.4. By Application 14.10. Timor-Leste Packaging Machines Sales Analysis 14.10.1. By Material 14.10.2. By Packaging Format 14.10.3. By Class 14.10.4. By Application 14.11. Laos Packaging Machines Sales Analysis 14.11.1. By Material 14.11.2. By Packaging Format 14.11.3. By Class 14.11.4. By Application 14.12. Rest of Southeast Asia Countries Packaging Machines Sales Analysis 14.12.1. By Material 14.12.2. By Packaging Format 14.12.3. By Class 14.12.4. By Application 15. Sales Structure Analysis 15.1. Sales Analysis by Tier of Companies 15.2. Sales Share Analysis of Top Players 15.3. Sales Presence Analysis 16. Competition Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Competition Deep Dive/ Portfolio Analysis (Key Sales Players with operations in Southeast Asia) 16.3.1. Sonoco Products Company 16.3.1.1. Overview 16.3.1.2. Product Portfolio 16.3.1.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.1.4. Sales Footprint 16.3.1.5. Strategy Overview 16.3.2. Amcor plc 16.3.2.1. Overview 16.3.2.2. Product Portfolio 16.3.2.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.2.4. Sales Footprint 16.3.2.5. Strategy Overview 16.3.3. Berry Southeast Asia, Inc. 16.3.3.1. Overview 16.3.3.2. Product Portfolio 16.3.3.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.3.4. Sales Footprint 16.3.3.5. Strategy Overview 16.3.4. Huhtamaki Oyj 16.3.4.1. Overview 16.3.4.2. Product Portfolio 16.3.4.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.4.4. Sales Footprint 16.3.4.5. Strategy Overview 16.3.5. PAXXUS PTE LTD 16.3.5.1. Overview 16.3.5.2. Product Portfolio 16.3.5.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.5.4. Sales Footprint 16.3.5.5. Strategy Overview 16.3.6. TPN Medical Packaging 16.3.6.1. Overview 16.3.6.2. Product Portfolio 16.3.6.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.6.4. Sales Footprint 16.3.6.5. Strategy Overview 16.3.7. Du Pont Inc 16.3.7.1. Overview 16.3.7.2. Product Portfolio 16.3.7.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.7.4. Sales Footprint 16.3.7.5. Strategy Overview 16.3.8. Graphic Packaging International, Inc. 16.3.8.1. Overview 16.3.8.2. Product Portfolio 16.3.8.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.8.4. Sales Footprint 16.3.8.5. Strategy Overview 16.3.9. West Pharmaceutical Services Inc 16.3.9.1. Overview 16.3.9.2. Product Portfolio 16.3.9.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.9.4. Sales Footprint 16.3.9.5. Strategy Overview 16.3.10. Steripack Group 16.3.10.1. Overview 16.3.10.2. Product Portfolio 16.3.10.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.10.4. Sales Footprint 16.3.10.5. Strategy Overview 16.3.11. ZACROS Group 16.3.11.1. Overview 16.3.11.2. Product Portfolio 16.3.11.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.11.4. Sales Footprint 16.3.11.5. Strategy Overview 16.3.12. Tekni-Plex, Inc. 16.3.12.1. Overview 16.3.12.2. Product Portfolio 16.3.12.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.12.4. Sales Footprint 16.3.12.5. Strategy Overview 16.3.13. Stora Enso Oyj 16.3.13.1. Overview 16.3.13.2. Product Portfolio 16.3.13.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.13.4. Sales Footprint 16.3.13.5. Strategy Overview 16.3.14. WestRock Company 16.3.14.1. Overview 16.3.14.2. Product Portfolio 16.3.14.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.14.4. Sales Footprint 16.3.14.5. Strategy Overview 16.3.15. Constantia Flexibles Group GmbH 16.3.15.1. Overview 16.3.15.2. Product Portfolio 16.3.15.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.15.4. Sales Footprint 16.3.15.5. Strategy Overview 16.3.16. Oliver Healthcare Packaging LLC 16.3.16.1. Overview 16.3.16.2. Product Portfolio 16.3.16.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.16.4. Sales Footprint 16.3.16.5. Strategy Overview 16.3.17. SGS SA 16.3.17.1. Overview 16.3.17.2. Product Portfolio 16.3.17.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.17.4. Sales Footprint 16.3.17.5. Strategy Overview 16.3.18. TAKO ASTATIC TECHNOLOGY SDN BHD. 16.3.18.1. Overview 16.3.18.2. Product Portfolio 16.3.18.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.18.4. Sales Footprint 16.3.18.5. Strategy Overview 16.3.19. CCB Medical Devices Sdn. Bhd. 16.3.19.1. Overview 16.3.19.2. Product Portfolio 16.3.19.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.19.4. Sales Footprint 16.3.19.5. Strategy Overview 16.3.20. UNIP BERHAD. 16.3.20.1. Overview 16.3.20.2. Product Portfolio 16.3.20.3. Profitability by Sales Segments (Material/ Packaging Format/ Application/Channel/Country) 16.3.20.4. Sales Footprint 16.3.20.5. Strategy Overview *The above list is indicative in nature and is subject to change during research 17. Assumptions and Acronyms Used 18. Research Methodology
Explore Packaging Insights
View Reports
Industry Analysis of Medical Device Packaging in Southeast Asia
